Access 2.8M+ Filings Sign Up Free
Celyad Oncology SA Logo

Celyad Oncology SA | CYAD - Profile, Filings, Stock Info & Investor Relations Data

Celyad Oncology SA | CYAD
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Belgium
Founded
2004
Celyad Oncology SA (CYAD)

Company Profile

Website
Investor Relations

About Celyad Oncology SA

Celyad Oncology is a biotechnology company focused on the research and discovery of chimeric antigen receptor T cell (CAR T) therapies for cancer. The Company is focusing on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property and support the development of next-generation CAR T candidates in solid tumors and hematological malignancies.

Market Presence

Worldwide

Headquarters

RUE ANDRE DUMONT 9
1435, MONT-SAINT-GUIBERT
Belgium

Company Video

Video thumbnail
Click to load video from YouTube

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Celyad Oncology SA (CYAD)
Filings & Annual Reports

Filters

Quick Filters:
View all types
Filing Information Actions
Loading filings...

Insider Trading Activity

◆
Kane Matthew (Board)
Other EUR 279,642.78 EUR 0.27 28.11.24
◆
Piscitelli Dominic (Board)
Other EUR 2,700.00 EUR 0.27 26.11.24
◆
Iserentant Hannes (Executive member)
Other EUR 8,100.00 EUR 0.27 25.11.24
◆
Phan An (Executive member)
Other EUR 8,100.00 EUR 0.27 22.11.24
◆
Goblet Serge (Board)
Other EUR 2,700.00 EUR 0.27 06.11.24
◆
Udier Blagovic Marina (Board)
Other EUR 2,700.00 EUR 0.27 05.11.24

Celyad Oncology SA (CYAD)
Stock & Investor Information

ISINs

BE0974260896
US1512051012
US1512052002

LEI

549300ORR0M8XF56OI64

Stock Exchange Listings

Euronext Brussels

Primary Stock Exchange Listing

View Celyad Oncology SA on main exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology